A multicenter, randomized, open-label, comparative, phase IV study to evaluate the efficacy and safety of combined treatment with mycophenolate mofetil and corticosteroids in advanced immunoglobulin A nephropathy

A multicenter, randomized, open-label, comparative, phase IV study to evaluate the efficacy and safety of combined treatment with mycophenolate mofetil and corticosteroids in advanced immunoglobulin A nephropathy

Background It remains unclear whether immunosuppressive agents are effective in patients with immunoglobulin A nephropathy (IgAN). We investigated the efficacy of a mycophenolate mofetil (MMF) and corticosteroid combination therapy in patients with advanced IgAN. Methods We conducted a multicenter,...

Full description

Bibliographic Details
Main Authors: Sang Youb Han, Chan-Young Jung, Sang Ho Lee, Dong Won Lee, Sik Lee, Chan-Duck Kim, Bum Soon Choi, Beom Seok Kim
Format: Article
Language:English
Published: The Korean Society of Nephrology 2022-07-01
Series:Kidney Research and Clinical Practice
Subjects:
corticosteroids
iga nephropathy
immunosuppressants
mycophenolate mofetil
proteinuria
Online Access:http://www.krcp-ksn.org/upload/pdf/j-krcp-21-146.pdf

Internet

http://www.krcp-ksn.org/upload/pdf/j-krcp-21-146.pdf

Similar Items